Endocrine

Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis (2022)

Our subgroup analysis revealed a 1.2-fold increased risk of developing diabetes after COVID-19 compared to patients with other upper respiratory tract infections and a 1.82-fold increased risk of developing diabetes after COVID-19 compared to the general population.

Risks and burdens of incident diabetes in long COVID: a cohort study (2022)

Risks and burdens of post-acute COVID-19 diabetes outcomes by severity of the acute infection compared with the contemporary control group, from The Lancet Diabetes & Endocrinology.